InSite One Inc.

InSite One hopes to provide hospitals with an archiving solution that accommodates radiologists' needs for on-line and off-line storage of images and short and long-term access to those images. The company will operate under a fee-for-service model that will relieve hospitals of the expense and obsolescence risk of buying capital equipment.

Image archiving is a throwback in the evolution of digital radiology. Today, many medical centers have the ability to digitally capture medical images acquired from computed radiography (CR), CT scans, MRI, or nuclear medicine. Radiologists can, within minutes, manipulate such images on a workstation, run them through pattern recognition software that helps in interpretation, and send them over the Internet to clinicians in remote locations. But six months later, if a clinician wants to call back images, at most hospitals —even those select few hospitals that are digitally equipped from one end to the other— the process works something like this: A departmental clerk goes to the hospital file room with a shopping cart and fills it with envelopes containing archived, film-based studies. Turn-around time on old film requests—four hours to two days, with 5-8% lost or missing rate. So much for progress.

Hospitals lack sufficient capacity to archive images electronically. Ironically, images that are acquired digitally are often converted to film for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By 

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.

More from Business

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By 

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By 

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.